Colgate-Palmolive (CL) Stock
$96.55
−2.17% Close Nov 6
CL stock is sideways, in Stage 2 (advancing) on the Weinstein method, and does not meet the Minervini Trend Template.
Open interactive chartCL stock price and performance
CL stock trades on the NYSE in the Consumer Defensive sector and the Household & Personal Products industry. Colgate-Palmolive is headquartered in New York, NY, United States. The live price table and chart beside this text show quotes, returns and moving-average lines as they update each session. Use those tables for every price reading on this page.
- Last close
- $96.55
- Day range
- $95.30 to $97.46
- 52-week range
- $75.96 to $101.18
- From 52-week high
- −4.6%
- Average volume (50 days)
- 5.2M
- 1 week
- +1.3%
- 1 month
- +9.6%
- 3 months
- +3.7%
- Year to date
- +22.2%
- 1 year
- +25.5%
- 3 years
- +28.9%
- 5 years
- +26.7%
Is CL stock in an uptrend?
Not yet. CL stock is not in an uptrend by our rules: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is above its 200-day moving average.
CL stock is in a sideways trend by the trend rules on this page. It does not meet the Minervini Trend Template. Two Daily Pivot Breakout momentum filters measure the 100-day rate of change and the 100-day EMA slope, each compared with a minimum. Under the Weinstein method, CL stock is in Stage 2 (advancing), the stage defined as a price above a rising 30-week moving average. The 30-week average tracks the long-term direction of the stock, and Mansfield relative strength measures how the stock performs against the broader market.
- Daily Pivot momentum filters
- 0 of 2 active
- 100-day ROC
- +6.5% filter at 40%: off
- 100-day EMA slope
- +3.9% filter at 25%: off
- Trend state
- Sideways
- Minervini Trend Template
- Not met on the latest scan
- 50-day average
- Above
- 150-day average
- Above
- 200-day average
- Above
- 200-day slope (1 month)
- +1.52%
- ATR (14) % of price
- 2.72%
Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.
Is CL stock in a Stage 2 uptrend?
Yes, CL stock is in a Stage 2 uptrend by our Weinstein stage analysis: its price is above a rising 30-week moving average and it is outperforming SPY.
- Weinstein stage
- Stage 2 (advancing)
- 30-week SMA
- $90.16
- 30-week slope (4 weeks)
- +1.54%
- Mansfield RS vs SPY
- 6.98
- Weeks in Stage 2
- 2
Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.
CL support and resistance levels
The levels table marks the pivot high, the pivot low and the moving-average lines for CL stock. Pivot high and pivot low lines show the swing points the scanners detected. Moving-average lines show the 50-day, 150-day and 200-day averages. Each line is a reference level, and the table lists the distance between each line and the quote.
| Level | Price | From close |
|---|---|---|
| Daily Pivot resistance (pivot high) | $97.50 | +1.0% |
| 9-day EMA | $96.11 | −0.5% |
| 21-day EMA | $94.01 | −2.6% |
| Latest Daily Pivot low | $90.47 | −6.3% |
| 30-week SMA | $90.16 | −6.6% |
| 50-day SMA | $90.14 | −6.6% |
| 200-day SMA | $89.99 | −6.8% |
| 150-day SMA | $89.68 | −7.1% |
Levels above the close act as resistance, levels below as support. Last close $96.55.
CL breakout and scanner signals
The page tracks VCP, RSI Divergence, Weinstein Stage Analysis, Daily Pivot Breakout, Minervini Trend Template, Episodic Pivot, Ichimoku TK cross, 9/21 EMA cross, Golden / Death Cross and RS Rating scanners for CL stock. The signal table lists the signal dates and directions for each scanner that has fired on the stock. Scanner results are reference data and do not forecast future moves.
| Scanner | Last signal (free view, 5 sessions late) | Past year |
|---|---|---|
| VCP | None in the last year | 0 |
| RSI Divergence | Jan 12, 2026 | 1 |
| Weinstein Stage Analysis | Oct 30, 2026A more recent signal (last 5 sessions) is in the journal. | 19 |
| Daily Pivot Breakout | None in the last year | 0 |
| Minervini Trend Template | None in the last year | 0 |
| Episodic Pivot | None in the last year | 0 |
| Ichimoku TK cross | Oct 15, 2026 | 11 |
| 9/21 EMA cross | Oct 12, 2026 | 17 |
| Golden / Death Cross | Oct 21, 2026 (bearish)A more recent signal (last 5 sessions) is in the journal. | 2 |
| RS Rating | None in the last year | 0 |
CL seasonality by month
CL stock has historically been strongest in November and weakest in September. The seasonality section of the page reflects these monthly patterns. Readers can compare those months with the price and return tables to see how the stock has moved in each calendar month.
- Jan−0.4%38% up
- Feb+0.3%48% up
- Mar+1.6%67% up
- Apr+0.6%70% up
- May+0.7%59% up
- Jun+0.9%52% up
- Jul−0.5%52% up
- Aug−0.1%48% up
- Sep−0.8%48% up
- Oct+0.7%59% up
- Nov+1.9%69% up
- Dec+1.1%58% up
Average monthly return over 26+ years of stored daily closes, and the share of years each month closed higher.
CL earnings history
CL stock last reported quarterly results on Oct 30, 2026, and those results came in above the estimate. The statements and earnings figures on this page give the detail behind that report.
| Reported | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Oct 30, 2026 | $0.93 | $0.97 | +4.3% |
| Jul 31, 2026 | $0.95 | $0.99 | +4.2% |
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% |
| May 1, 2026 | $0.94 | $0.97 | +3.2% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% |
CL bull and bear case
Bullish factors for CL stock include the Stage 2 (advancing) Weinstein reading and a last reported quarter that came in above the estimate. Bearish factors include the sideways trend state and the fact that the stock does not meet the Minervini Trend Template. These factors come only from the trend state, Weinstein stage, Template status and earnings result.
What looks strong
- Stage 2 uptrend by our Weinstein stage analysis scanner.
- Price is above a rising 200-day moving average.
What looks weak
- Neither Daily Pivot momentum filter is active (100-day ROC 6.5%, 100-day EMA slope 3.9%; the filters need 40% and 25%).
- Does not meet the Minervini Trend Template on the latest scan.
Drawn only from the data on this page. Not a recommendation.
CL news and SEC filings, last 30 days
The filings table lists SEC filings for CL stock, with form names and filing dates as they are recorded. Readers can use the table to review the company's submitted reports in one place. The table updates as new filings are added.
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
- 8-KQuarterly or annual results; Exhibits
- 10-QQuarterly report (10-Q)
Source: SEC EDGAR.
CL insider trading and risks
The insider table lists reported insider transactions in CL stock, including the transaction type and direction for each entry. Readers can scan the table to see whether recorded trades are purchases or sales. The table shows only the trades that have been reported.
- Buys, last 90 days
- 0 ($0)
- Sales, last 90 days
- 3 ($6.3M)
- Buys, last 12 months
- 0 ($0)
- Sales, last 12 months
- 3 ($6.3M)
| Date | Insider | Trade | Value |
|---|---|---|---|
| Nov 4 | Hazlin JohnChief Growth Officer | Sale 23,376 shares | $2.3M |
| Nov 5 | Wallace Noel R.Director, Chairman, President & CEO | Sale 20,000 shares | $2.0M |
| Nov 4 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Sale 19,938 shares | $2.0M |
Insider trades: SEC Form 4 open-market purchases and sales.
CL valuation and fundamentals
CL stock has valuation data on this page. The valuation table shows the measures recorded for Colgate-Palmolive, and those figures update as the price moves. Readers can review the table alongside the trend and earnings sections.
- Market cap
- $76.76B
- Enterprise value
- $83.21B
- P/E (trailing)
- 37.6
- P/E (forward)
- 23.6
- PEG
- -6.91
- Price to sales
- 3.61
- Price to book
- 266.74
- EV to EBITDA
- 16.5
- Gross margin
- +61.5%
- Operating margin
- +20.4%
- Profit margin
- +9.6%
- Return on equity
- +231.7%
- Revenue (TTM)
- $21.28B
- Revenue growth (quarter, y/y)
- +4.6%
- Cash
- $1.61B
- Debt
- $7.72B
- Beta
- 0.31
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $20.38B | $2.26B | $3.63B |
| 2024 | $20.10B | $3.05B | $3.59B |
| 2023 | $19.46B | $2.46B | $3.44B |
| 2022 | $17.97B | $1.97B | $2.04B |
CL dividends and splits
CL stock pays a dividend. The dividend table lists the payment dates and amounts for each distribution on record. Readers can use the table to follow the dividend history for the stock.
- Dividend yield
- 2.20%
- Payout ratio
- 81.7%
Recent dividends: Jul 20, 2026 $0.53, Apr 20, 2026 $0.53, Jan 21, 2026 $0.52, Oct 17, 2025 $0.52, Jul 18, 2025 $0.52, Apr 17, 2025 $0.52
Stock splits: 2-for-1 split on May 16, 2013, 2-for-1 split on Jul 1, 1999, 2-for-1 split on May 16, 1997, 2-for-1 split on May 16, 1991, 3-for-1 split on May 30, 1973.
Who owns CL?
- Shares outstanding
- 797.2M
- Float
- 746.1M
- Held by insiders
- +0.2%
- Held by institutions
- +86.8%
- Short interest (% of shares)
- +2.5%
- Days to cover
- 3.2
What does Colgate-Palmolive Co. do?
Colgate-Palmolive Co. is a global consumer products company focused on oral care, personal care, home care, and pet nutrition. Its brands include Colgate, Palmolive, Softsoap, Speed Stick, Fabuloso, and Hill's Science Diet. The company sells through traditional retail, e-commerce, wholesale, dental, skin health, and veterinary channels in markets worldwide. It supplies essential products to households, professionals, and pet owners.
- CEO
- Mr. Noel R. Wallace
- Employees
- 33,600
- Headquarters
- New York, NY, United States
- Website
- colgatepalmolive.com
CL stock FAQ
Is CL stock in an uptrend?
Not yet. CL stock is not in an uptrend by our rules: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is above its 200-day moving average.
Is CL stock in a Stage 2 uptrend?
Yes, CL stock is in a Stage 2 uptrend by our Weinstein stage analysis: its price is above a rising 30-week moving average and it is outperforming SPY.
Does CL stock meet the Minervini Trend Template?
CL stock does not meet the Minervini Trend Template by the rules used on this page.
What are CL stock's support and resistance levels?
The levels table for CL stock marks the pivot high, the pivot low and the 50-day, 150-day and 200-day moving-average lines. Each line is a reference level, and the table lists the distance between each line and the quote.
When did CL stock last report earnings?
CL stock last reported quarterly results on Oct 30, 2026, and those results came in above the estimate. The statements on this page give the detail behind that report.
Are insiders buying or selling CL stock?
The insider table for CL stock lists reported insider transactions with the transaction type and direction for each entry. Readers can check that table to see whether the recorded trades are purchases or sales.
What is CL stock's best and worst month historically?
CL stock has historically been strongest in November and weakest in September. The seasonality section reflects these monthly patterns.
Does CL stock pay a dividend?
CL stock pays a dividend. The dividend table lists the payment dates and amounts for each distribution on record.
What are the main bullish and bearish factors for CL stock?
Bullish factors for CL stock include the Stage 2 (advancing) Weinstein reading and an earnings result that came in above the estimate. Bearish factors include the sideways trend state and the failure to meet the Minervini Trend Template.
What does CL do?
Colgate-Palmolive Co. is a global consumer products company focused on oral care, personal care, home care, and pet nutrition. Its brands include Colgate, Palmolive, Softsoap, Speed Stick, Fabuloso, and Hill's Science Diet.
What sector and industry is CL stock in?
CL stock is in the Consumer Defensive sector and the Household & Personal Products industry. It trades on the NYSE.
